Gary Lubin

Gary Lubin is a seasoned executive with extensive experience in the healthcare and pharmaceutical industry, currently serving as the CEO of Ledger Run, Inc., a company he co-founded in 2018.1 Ledger Run focuses on simplifying and expediting clinical trials through innovative technological solutions, particularly in the area of clinical trial financial management.2

Professional Background

Gary's career spans several decades and includes notable positions:

• Co-founder and CEO of Ledger Run, Inc. (2018-present)1
• Co-Lead at InRun Capital (2015 onwards)1
• CFO and EVP at PDR Network, LLC (2013-2015)1
• Founder and CEO of Centerphase Solutions (2008-2013)1
• Managing Director and CIO/CTO at Merck Capital Ventures (1992-2008)1

Education and Certifications

Gary Lubin holds:

• Bachelor of Science in Business Administration (BSBA) with a specialization in Accounting from Washington University in St. Louis - Olin Business School (1979-1982)1
• Master of Business Administration (MBA) from Harvard Business School (1984-1986)1
• Additional certifications: CGMA, CITP, and CPA1

Leadership at Ledger Run

At Ledger Run, Gary leads a team focused on accelerating the introduction of innovative medical treatments to improve patient well-being.2 The company's platform, ClinRun, aims to optimize workflows and streamline the clinical trial financial management process for sites, sponsors, and CROs.2

Gary Lubin's expertise in financial and information technology management, combined with his extensive experience in the healthcare and biopharmaceutical industry, positions him as a key figure in driving innovation in clinical trial management.